Oragenics Acquires Noachis Terra Inc., to Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing “Spike Protein”
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced its acquisition of UF Innovate | The Hub resident client Noachis Terra Inc., following its entry into a stock purchase agreement, to develop and […]
Just – Evotec Biologics to Collaborate With Ology Bioservices on Antibodies Against Coronavirus
Evotec SE, a drug discovery alliance and development partnership company focused on innovative product approaches with leading pharmaceutical and biotechnology companies, announced that its Seattle-based subsidiary Just – Evotec Biologics, Inc. has entered into a partnership with UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices, Inc., a biologics contract development and […]
Algernon Receives Clearance From Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, is pleased to announce that it has received a “No Objection” letter from Health Canada to proceed with NP-120 (Ifenprodil) COVID-19 Phase 2b/3 multinational clinical trial. The same study protocol is being prepared for submission to the U.S. FDA and Australian regulatory authorities. “The study […]
New Molekule Air Mini+ Keeps Your Home’s Air Clean Automatically
It’s been weeks and, more than any place else, your home is where you’ve spent the majority of your time. Is it getting a little musty? Especially if you’re living in a part of the country that’s seen late Spring snow storms, popping open a window might not be an option. Luckily, UF startup Molekule […]
Foundation Park Building Sells for $12M
Avison Young real estate services announced the sale of a $12 million, newly-constructed 43,180-square-foot biotech and life science research facility at Foundation Park in Alachua. The sale, the largest in Alachua County since 2015 and part of a 1031 exchange, is the first of four buildings that are scheduled to be developed for UF Innovate […]
Unique Sensors Will Improve Aerodynamic Design, Aircraft Performance
Even after almost 150 years of wind tunnel testing, no commercial product had ever been able to directly measure the localized force that passing air exerts on the surface of a vehicle model—until now. Known in the industry as wall shear stress, or skin friction, the force is a major factor in a vehicle’s drag, […]
A Blood Test to Detect Traumatic Brain Injury
Traumatic brain injury (TBI) is hard to detect, and is sometimes called the “invisible injury.” Ron Hayes and Nancy Denslow, both scientists at the McKnight Brain Institute and the founders of UF startup and UF Innovate | Sid Martin Biotech alum Banyan Biomarkers, have developed a blood-based test that will make TBI detection and treatment […]
Full Interview: Algernon Pharmaceuticals Receives OK From South Korea for Phase Two Study of Ifenprodil
Christopher Moreau, CEO of UF startup Algernon Pharmaceuticals, a clinical-stage pharmaceutical development company, joined Steve Darling from Proactive in Vancouver with big news. The company has received approval from the Ministry of Food and Drug Safety in South Korea for a Phase 2 COVID-19 clinical study of their repurposed drug Ifenprodil . Moreau shares with Proactive […]
Ology Bioservices to Adapt Veroplex Cell Platform for Rapid Response to Viral Threats for Department of Defense
The Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnologies has awarded a contract valued at $27.3 million to UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), to establish their proprietary Veroplex cell platform for rapid response to […]
Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
UF startup Algernon Pharmaceuticals Inc., a clinical-stage pharmaceutical development company, is pleased to announce that it has submitted a Clinical Trial Application (CTA) to Health Canada for an NP-120 (Ifenprodil) COVID-19 Phase 2b/3 multinational clinical trial. The same study protocol is being prepared for submission to the U.S. FDA and Australian regulatory authorities. The study […]